The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 06, 2026
Filed:
Dec. 04, 2020
Applicants:
Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, CN;
Ascentage Pharma Group Corp Limited, Hong Kong, CN;
Inventors:
Yifan Zhai, Suzhou, CN;
Dajun Yang, Suzhou, CN;
Douglas Dong Fang, Suzhou, CN;
Guangfeng Wang, Suzhou, CN;
Jing Deng, Suzhou, CN;
Qiuqiong Tang, Suzhou, CN;
Ran Tao, Suzhou, CN;
Assignees:
Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, CN;
Ascentage Pharma Group Corp Limited, Hong Kong, CN;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/635 (2006.01); A61K 31/138 (2006.01); A61K 31/47 (2006.01); A61K 31/496 (2006.01); A61K 31/517 (2006.01); A61K 31/519 (2006.01); A61K 31/553 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/635 (2013.01); A61K 31/138 (2013.01); A61K 31/47 (2013.01); A61K 31/496 (2013.01); A61K 31/517 (2013.01); A61K 31/519 (2013.01); A61K 31/553 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01);
Abstract
Described herein are methods of treating a cancer, for example, a hematologic malignancy or a solid tumor, in a patient in need thereof, comprising administering to the patient a Bcl-2 inhibitor in combination with a second anti-cancer agent.